Profil
Patric Trojer served as the Chief Scientific Officer at Constellation Pharmaceuticals, Inc. from 2018 to 2021.
Prior to that, he held other positions at the same company from 2008.
Trojer received a graduate and doctorate degree from the University of Innsbruck.
Anciens postes connus de Patric Trojer
| Sociétés | Poste | Fin |
|---|---|---|
| CONSTELLATION PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 15/07/2021 |
Formation de Patric Trojer
| University of Innsbruck | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Constellation Pharmaceuticals, Inc.
 Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Constellation Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics in the field of epigenetics. The firm utilizes epigenetics platform, which enables to validate targets and generate small molecules against these targets that selectively modulate gene expression in tumor and immune cells to drive anti-tumor activity. Its product include CPI-0610, CPI-1205, and CPI-0209. The company was founded by Danny Reinberg, David Allis, and Yang Shi on January 11, 2008 and is headquartered in Cambridge, MA. | Health Technology |
